ESC 365 - RNA-based inhibitors to correct dyslipidemia.

ESC Premium Access

RNA-based inhibitors to correct dyslipidemia.

Session: The promise of RNA-based therapeutics and diagnostics

Topic: Genetics, Epigenetics, ncRNA

Speaker: Professor K. Ray (London, GB)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

91 presentations

16 followers

3 more presentations in this session

Extracellular vesicles as RNA delivery systems: how far we are from their therapeutic or diagnostic use?

Speaker: Professor P. Ferdinandy (Budapest, HU)

Light activated RNA therapeutic strategies.

Speaker: Professor S. Dimmeler (Frankfurt, DE)

Circulating microRNAs as diagnostic biomarkers

Speaker: Doctor D. De Gonzalo Calvo (Barcelona, ES)

Access the full session

The promise of RNA-based therapeutics and diagnostics

Speakers: Professor K. Ray, Professor P. Ferdinandy, Professor S. Dimmeler, Doctor D. De Gonzalo Calvo

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources